drugset / Trial / NCT05919147
The Neuroendocrine Effects of Pioglitazone in Patients With Cancer and Cachexia
RandomizedParallel-groupTriple-blindSupportive care
Summary
The goal of this clinical trial is evaluate the effect of pioglitazone compared with placebo on skeletal muscle insulin sensitivity in subjects with cancer and cachexia.
Timeline
- Start
- 2024-01-03
- Primary completion
- 2025-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pioglitazone | Small molecule | 45 mg | — |